Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy

Cancer Journal from Scientific American

Volumn 4, Issue 5, 1998, Pages 324-330

  Do, Tri ^a   Parker, Robert G ^a   Do, Cong ^a   Tran, Luu ^b   Do, Ly ^c   Dolkar, Dechen ^a  

^a UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Prostate; Prostatectomy; Radiation; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RELAPSE; SALVAGE THERAPY; TREATMENT FAILURE; TUMOR LOCALIZATION;

ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; SALVAGE THERAPY;

EID: 0031663404     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jones GW, Mettlin C, Murphy GP et al. Patterns of care for carcinoma of prostate gland: results of a national survey of 1984 and 1990. J Am Coll Surg 1995;180:545-554.
2. Mettlin C, Murphy GP, Menck H. Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the commission on National Cancer Database, 1985-1990. Urology 1994;43:488-492.
3. Takayama TK, Lange PH. Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol Clin North Am 1994;21:687-700.
4. Zietman AL, Shipley WU, Willett CG. Residual disease after radical surgery or radiation therapy for prostate cancer. Cancer 1993; 71:959-969.
5. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994;152:1837-1842.
6. Hudson MA, Catalona WJ. Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J Urol 1990;143:1174-1177.
7. Lange PH, Ercole CJ, Lightner DJ, et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989;141:837-839.
8. Nelson WG, Simons JW. New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy. Urol Clin North Am 1996;23:685-696.
9. Lightner DJ, Lange PH, Reddy PK. Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 1990;144:921-926.
10. Middleton RG, Smith JA, Melzer RB. Patient survival and local recurrence rate following radical prostatectomy for prostate cancer. J Urol 1986;136:422-424.
11. Zietman AL, Shipley WU, Coen JJ. Radical prostatectomy and radiation therapy for clinical stages T1 and T2 adenocarcinoma of the prostate: new insights into outcome from repeated biopsy and prostate cancer specific antigen follow-up. J Urol 1994;152:1806-1812.
12. McCarthy JF, Catalona WJ, Hudson MA. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early vs. delayed treatments. J Urol 1994; 151:1575-1578.
13. Morris MM, Dallow KC, Zietman AL et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 1997;38:731-736.
14. Lange PH, Lightner DJ, Medini E et al. Effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 1990;144:927-933.
15. Zietman AL, Coen JJ, Shipley WU et al. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of the prostate: analysis of freedom from PSA failure. Urology 1993;42:292-299.
16. Link P, Freiha FS, Stamey TA. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 1991;145:532-534.
17. Schild SE, Wong WW, Grando GL et al. Radiotherapy for isolated increases in serum prostate specific antigen levels after radical prostatectomy. Mayo Clin Proc 1994;69:613-619.
18. Keisch ME, Perez CA, Grigsby PW et al. Preliminary report on 10 patients treated with radiation after radical prostatectomy for isolated elevations of serum PSA levels. Int J Radiat Oncol Biol Phys 1990;19:1503-1506.
19. Stamey TA, Yang N, Hay AR et al. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-916.
20. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
21. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
22. Syndikus I, Pickles T, Kostashuk E et al. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. J Urol 1996;155:1983-1986.
23. Raveny V, Boccon-Gibod LA, Meulemans A et al. Predictive value of pathologic features for progression after radical prostatectomy. Eur Urol 1994;26:197-201.
24. Bonin SR, Hanlon AL, Lee WR et al. Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer 1997;79:75-80.